Results 91 to 100 of about 23,258 (251)
Nonthermal plasma approaches for combating implant‐associated infections: A compendious review
Implant‐associated infections pose serious clinical challenges. Non‐thermal plasma (NTP) modifications overcome this bottleneck in distinct ways relative to traditional sterilization methods. Gas‐phase plasmas generate highly energetic species, UV radiation and reactive oxygen/nitrogen species (RONS), which alter the implant surface properties.
A. M. Trimukhe +8 more
wiley +1 more source
In this population‐based study of 616 older adults, we analyzed the associations of proton‐pump inhibitor (PPI) use with handgrip strength, 4‐m walking performance, and armchair push–pull performance. After adjusted for age, sex, body mass index, and comorbidity burden using the Charlson Comorbidity Index (CCI), only the association with armchair push ...
Jaakko Ollila +6 more
wiley +1 more source
Abstract Background Family engagement is crucial for achieving successful outcomes for both patients and hospitals. It supports safe transitions between care settings, providers, and ultimately, as illness progresses. However, in the hospital setting, family engagement is poorly operationalized.
Jennifer Morgan +4 more
wiley +1 more source
Summary Introduction Day surgery is now recognised widely as being a vital component of modern healthcare delivery with overall day surgery rates in the UK now > 85%. Day surgery offers an enhanced experience for patients with reduced risk of postoperative complications (e.g.
Craig R. Bailey +8 more
wiley +1 more source
Severe abdominal aortic calcification on preoperative CT may identify vascular frailty in patients undergoing pancreaticoduodenectomy. Integrated with fistula‐risk scores and frailty assessment, it may inform discussion of standard PD versus planned total pancreatectomy in selected high‐risk patients, while AAC alone is not an indication for TP ...
Mohamed Hajri +3 more
wiley +1 more source
Summary The Hodgkin lymphoma treatment in the elderly (eHL) is a challenge due to a narrow therapeutic window between therapy effectiveness and toxicity. Both bendamustine (Be) and brentuximab vedotin (BV) are well‐tolerated, effective drugs in relapsing HL, but no data exist on Be‐BV frontline treatment in eHL.
Andrea Gallamini +15 more
wiley +1 more source
Geriatric oncology: Looking into grey scales
Rahul Ravind
doaj +1 more source
Are Cochlear Implants Indicated in the Advanced Aging Population?
The Laryngoscope, EarlyView.
India Jackson +2 more
wiley +1 more source

